Addiction

Article	Citations
Issue Information	221
Commentary on Borodovsky et al.: Enhancing research on THC quantification—Consumer awareness through accurate labelling	189
An Addiction series on regional perspectives on addiction‐related problems	94
Society for the Study of Addiction Annual Conference 2024	94
	90
	89
Impulsivity behaviors and white matter mediate the relationship between genetic risk for cannabis use disorder and early cannabis use in adolescents	85
Education matters: longitudinal pathways to mid‐life heavy drinking in a national cohort of black Americans	85
Will Australia's tightened prescription system reduce nicotine vaping among young people?	82
Commentary on Keyes and Patrick: Changes in psychedelic use in the United States may require changes in our narrative of psychedelic harms	72
Commentary on Nower et al: The Pathways Model should apply to non‐clinical gambling patterns	70
Significant changes in preference of illicit drug use in a population of Hanoi, Vietnam—A 6‐year wastewater study (2018–2023)	70
Structure and stability of internet gaming disorder from childhood to late adolescence: A 5‐wave birth cohort study	69
National profile on substance use, substance use‐related problems and policy: The case of Chile	69
	62
Estimating recent trends in alcohol sales in the United Kingdom from alcohol duty revenue	58
Does recreational cannabis legalization change cannabis use patterns? Evidence from secondary school students in Uruguay	55
Commentary on Lange et al.: Acute alcohol use before suicide—is it contributing to an increase in suicide rates in the United States?	53
Recent decline in Chinese alcohol production and consumption: Potential contributing factors and the role of globally recommended measures	52
The use of financial incentives for smoking cessation in pregnant women: A parallel‐group randomised controlled trial protocol	52
Chronic obstructive pulmonary disease in heroin users: An underappreciated issue with clinical ramifications	50
Use of cessation products, e‐cigarettes and cigarette cessation outcomes among adults with substance use problems: Results from 2013–2021 (Waves 1–6) of the Population Assessment of Tobacco and Health	47
Rare but relevant series	45
Naloxone administration—no balance without titration	44
How substance use prevention research gets used in United States federal policy	44

Response to Hall et al.: Prescription psychostimulants for amphetamine‐type stimulant use disorder ‐ acknowledging challenges but not giving up on its potential cost‐effectiveness	42
Commentary on Stull et al.: Considering person‐specific heterogeneity when modeling time‐varying trends	41
Quantifying alcohol‐attributable disability‐adjusted life years to others than the drinker in Aotearoa/New Zealand: A modelling study based on administrative data	39
Cost‐effectiveness of integrated treatment for hepatitis C virus (HCV) among people who inject drugs in Norway: An economic evaluation of the INTRO‐HCV trial	39
Did the under‐reporting of meth/amphetamine use increase in a general population survey in Australia as negative media coverage increased?	37
Assessing the impacts of alcohol outlets on crime as a natural experiment: agglomeration, churning and spatial effects	36
Nicotine strength of e‐liquids used by adult vapers in Great Britain: A population survey 2016 to 2024	35
Risk of readmission among individuals with cannabis use disorder during a 15‐year cohort study: the impact of socio‐economic factors and psychiatric comorbidity	34
Association of topiramate prescribed for any indication with reduced alcohol consumption in electronic health record data	34
Systematic review and meta‐analyses of cytisine to support tobacco cessation	32
ABC‐training as a new intervention for hazardous alcohol drinking: Two proof‐of‐principle randomized pilot studies	32
Austin Bradford Hill’s ‘Environment and disease: Association or causation’	31
Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial	31
Predictors of substance use during treatment for addiction: A network analysis of ecological momentary assessment data	31
England's disposable vape ban: An inadequate solution to youth vaping with potential unintended consequences	30
Non‐alcoholic beverage consumption among US adults who consume alcohol	30
New Books	30
Author Index	30
Age, period and cohort effects of heavy episodic drinking by sex/gender and socioeconomic position in Canada, 2000–2021	30
Risky alcohol consumption among women in Australia attending breast screening services: an exploratory cross‐sectional study	29
Longitudinal trajectories of marijuana use in tobacco products among young adult Texas college students from 2015 to 2019	28
Commentary on Metcalfe et al.: ‘What works in AOD is when it feels like I am driving’ (Craig W, alcohol and drug peer worker)	28
Neurophysiological error processing and addiction self‐awareness correlates of reduced insight in cannabis use disorder	28
Commentary on Lannoy et al.: The continued value of within‐family designs in addiction and psychiatric research	28
Are North Carolina clinicians delivering opioid use disorder treatment to Medicaid beneficiaries?	28
Clinical alcohol guidelines are welcome—but upstream action is paramount	27
Issue Information	27
	27
Issue Information	27
	27
Estimating the impact of a police education program on hepatitis C virus transmission and disease burden among people who inject drugs in Tijuana, Mexico: A dynamic modeling analysis	26
How research and policy can shape driving under the influence of cannabis	26
Age–period–cohort analysis of past 12‐month cannabis use in Germany (1995–2021)	25
Commentary on Motschman et al.: Moving behavioral economic demand into the real world means moving beyond single schedules of reinforcement	25
Impacts of recreational cannabis legalization on cannabis use: a longitudinal discordant twin study	25
Commentary on Luukkonen et al.: Policy possibilities for reducing public health harms related to pregnant people’s alcohol consumption	25
Commentary on Amin‐Esmaeili et al .: Non‐abstinence outcomes in stimulant clinical trials—Why deny improvement?	25
Perspectives on addiction‐related problems in India	25
Changes in wastewater measures of alcohol consumption in Alice Springs, Australia, 1 year after the introduction of restrictions on alcohol sales	24
Age‐based differences in quantity and frequency of consumption when screening for harmful alcohol use	24
Drug Overdoses During the COVID‐19 Pandemic Among Recently Homeless Individuals	24
The association between family environment and food addiction in children and adolescents: A prospective cohort study	24
Obstetric pain management for pregnant women with opioid use disorder: A qualitative and quantitative comparison of patient and provider perspectives (QUEST study)	23
Identifying and describing trajectories of alcohol use frequency and binge drinking frequency among those aged 15–30 years in a national cohort of US adolescents: A group‐based trajectory modeling app	23
	23
Implications of the shift to DSM‐5 for alcohol use disorder prevalence estimates in the National Survey on Drug Use and Health	23
Evaluating the causal effect of tobacco smoking on white matter brain aging: a two‐sample Mendelian randomization analysis in UK Biobank	23
A return on investment analysis for the 2017 increase in alcohol excise taxation in Lithuania	23
Identifying patients with opioid use disorder using International Classification of Diseases (ICD) codes: Challenges and opportunities	23
Pain in people seeking and receiving opioid agonist treatment: A systematic review and meta‐analysis of prevalence and correlates	23

A comparative study of treatment retention in opioid use disorder: Subcutaneous injectable versus sublingual buprenorphine	23
Genetic support of a causal relationship between cannabis use and educational attainment: a two‐sample Mendelian randomization study of European ancestry	23
Cannabis research in context: The case for measuring and embracing regional similarities and differences	23
Systematic review of symptom‐level networks of alcohol use disorder	22
Issue Information	22
New Books	22
Effect of vaping on past‐year smoking cessation success of Australians in 2019—evidence from a national survey	22
Deficits in general and smoking‐specific response inhibition in the Go/No‐Go task in individuals who smoke: A cross‐sectional analysis	22
Issue Information	21
The Opioid Epidemic in the United States: Missed Opportunities and Policy Failures. By Kant B.Patel & Mark E.Rushefsky, London, UK: Routledge, 2022. ISBN: 9781032105215	21
Commentary on Schmidt et al.: Informed patient preference and prioritizing access to medications for opioid use disorder for pregnant individuals	21
Issue Information	21
‘It's not what you'd term normal smoking’: a qualitative exploration of language used to describe heated tobacco product use and associated user identity	21
Social genetic effects for drug use disorder among spouses	21
Issue Information	21
	21
Prosecuting Poverty, Criminalizing Care. By WendyBach, Cambridge, UK: Cambridge University Press. 2022. ISBN: 9781108465533	21
Changing patterns of nicotine product use and nicotine dependence among United States high‐school students: The National Youth Tobacco Survey, 2014–2023	20
Disentangling the contributions of alcohol use disorder and alcohol‐related liver disease towards dementia: A population‐based cohort study	20
	20
Drugs, Identity and Stigma. By MichelleAddison, WilliamMcGovern & RuthMcGovern. Chan, Switzerland: Palgrave Macmillan, 2022. ISBN: 9783030982867	20
Commentary on Petrilliet al.: Assessing cannabis use in real‐world settings ‐ advances using standard THC units	20
Fatal drug overdoses in healthcare workers: A thematic framework analysis of coroner reports	20
Commentary on Brothers et al.: The role of safer environment interventions in addressing injecting‐related bacterial and fungal infections	20
New perspectives on how to formulate alcohol drinking guidelines: Response to commentaries	20
Outdated tools, underestimated harm: Modernizing cannabis surveillance in a post‐legalization era	19
Effectiveness and safety of psychosocial interventions for the treatment of cannabis use disorder: A systematic review and meta‐analysis	19
‘I'd rather have worse gums than worse lungs’: Young people's views of nicotine pouches in the UK	19
Evaluating the impact of vaping facts films on vaping harm perceptions among young adults in the UK: A randomized on‐line experiment	19
Psychedelic‐assisted treatment for substance use disorder: A narrative systematic review	19
Development of a novel risk score reflecting the relative harm potential of synthetic cannabinoids based on prevalence estimates, well‐documented intoxication cases and basic pharmacological data	19
Cannabis vaping and mental health: The association of Δ‐9‐tetrahydrocannabinol and cannabidiol with anxiety and depressive symptoms—Findings from the United States National Youth Tobacco Survey (2021–	19
Nicotine pouch use by sex, school type and tobacco product use among Finnish adolescents during the 2023 change in regulatory scheme with deregulated sales	19
Patient outcomes following buprenorphine treatment for opioid use disorder: A retrospective analysis of the influence of patient‐ and prescriber‐level characteristics in Massachusetts, USA	19
Non‐invasive brain stimulation for smoking cessation: a systematic review and meta‐analysis	19
Sludge, dark patterns and dark nudges: A taxonomy of online gambling platforms' deceptive design features	18
New Books	18
Rare but relevant: Hydrocarbons and sudden sniffing syndrome	18
Response to Xiao et al.: If everything is a loot box, nothing is	18
Early identification of the use of potent benzylbenzimidazoles (nitazenes) through wastewater analysis: Two years of data from 22 countries	18
Commentary on Jones et al.: We must consider emergency medical services data an opportunity for a view into a community	18
Addiction Lives: Sir Ian Gilmore	18
The interaction of e‐cigarette use and mental health symptoms on risk of cigarette smoking initiation among young adults in the United States	18
Commentary on Craft et al.: Drug contaminants and substitutions in illicit vapes represent a major health risk	18
Issue Information	18
Multivariable machine learning prediction of risky alcohol use in contemporary youth	17
Offering e‐cigarettes for smoking cessation and reduction in people with mental illness (ESCAPE): Protocol for a randomized controlled trial	17
What policies the US Food and Drug Administration should pursue in response to the addiction and overdose crisis	17
The price of a cigarette: 20 minutes of life?	17
Changes to opioid overdose deaths and community naloxone access among Black, Hispanic and White people from 2016 to 2021 with the onset of the COVID‐19 pandemic: An interrupted time‐series analysis in	17
Medications for opioid use disorder: Predictors of early discontinuation and reduction of overdose risk in US military veterans by medication type	17
Daily associations between sleep and alcohol use among veterans: Acute and cumulative effects	17
How people decide to consume (more) alcohol when feeling stressed	17
Alcohol drinking, DNA methylation and psychiatric disorders: A multi‐omics Mendelian randomization study to investigate causal pathways	17
Addiction Lives: Robin Davidson	17
Challenges and opportunities for further research involving the cannabis‐to‐opioid use transition	17
Commentary on Yang et al.: The need for a renewed focus on identifying and responding to chronic pain among people with substance use disorders	16
How to interpret studies on the impact of legalizing cannabis	16
The advantages and downsides of online focus groups for conducting research on addictive online behaviours	16
Disparities in the receipt of alcohol brief intervention: The intersectionality of sex, age, and race/ethnicity	16
Issue Information	16
Commentary on Sun and Tang: Measurement assessment and validity in problematic smartphone use	16
Do internalising or externalising behaviours in adolescence mediate the child maltreatment‐alcohol substance use relationship?	16
Differences in benefits of office based opioid treatment: Secondary analyses across sub‐groups in the PROUD randomized controlled implementation trial	16
Could alcohol‐free and low‐alcohol beverages be used to extinguish alcohol cravings?	16
Rapid growth in disposable e‐cigarette vaping among young adults in Great Britain from 2021 to 2022: a repeat cross‐sectional survey	16
New Books	16
Should contingency management protocols and dissemination practices be modified to accommodate rising stimulant use and harm reduction frameworks?	16
Striatal dopamine D2 receptor availability as a predictor of subsequent alcohol use in social drinkers	16
Systematic review and meta‐analysis investigating nicotine, cotinine and carbon monoxide exposures in people who both smoke and use nicotine replacement therapy	16
Motivational smoking cessation counselling and community‐based follow‐up after hospitalisation for vascular disease: A randomised controlled trial	16
Effect of a workplace mobile phone‐based instant messaging intervention on smoking cessation: a cluster‐randomized controlled trial	16
	16
Prescribing of extended release buprenorphine injection for Medicaid beneficiaries, 2018–2022	15
Mainstreaming smoking cessation brief advice in health systems using the United Nations human rights system	15
Commentary on Jackson et al.: The role of regional tobacco control in centralised nations	15
Better data access can lead to better collaborative conclusions: Results of a discussion with Heirene	15
Yes, nitrous oxide addiction undeniably exists!	15
Issue Information	15
Issue Information	15

The efficacy of an internet‐based cognitive behavioral program added to treatment‐as‐usual for alcohol‐dependent patients in primary care: a randomized controlled trial	15
Issue Information	15
Evaluating the impact of minimum unit pricing for alcohol on road traffic accidents in Scotland after 20 months: An interrupted time series study	15
The geography of sobriety checkpoints and alcohol‐impaired driving	15
Stakeholders cannot simply wait for the gambling evidence‐base to develop: We must all help to build it	15
Commentary on Lin et al.: The importance of valid reference standards in training supervised machine learning classifiers to detect alcohol misuse	15
	15
Broad evidence of xylazine in the UK illicit drug market beyond heroin supplies: Triangulating from toxicology, drug‐testing and law enforcement	15
Addressing the overdose crisis in North America with bold action	14
Cannabis use disorder and adverse cardiovascular outcomes: A population‐based retrospective cohort analysis of adults from Alberta, Canada	14
Validating transdermal alcohol biosensors: a meta‐analysis of associations between blood/breath‐based measures and transdermal alcohol sensor output	14
Referees	14
Issue Information	14
Functional connectivity in the central executive network predicts changes in binge drinking behavior during emerging adulthood: an observational prospective study	14
Effects of interventions to combat tobacco addiction: Cochrane update of 2021 to 2023 reviews	14
Clinical characteristics of heroin overdose deaths among older adults in Australia, 2000–2025	14
The association between state cannabis policies and cannabis use among adults and youth, United States, 2002–2019	14
Cost–utility analysis of provision of e‐cigarette starter kits for smoking cessation in emergency departments: An economic evaluation of a randomized controlled trial	14
Issue Information	14
Cannabis use and sleep problems among young adults by mental health status: A prospective cohort study	14
Zero tolerance for 0%? How should clinicians and other practitioners respond to the use of alcohol‐free and low‐alcohol products in higher risk groups	14
Harmful compared to what? The problem of gaming and ambiguous causal questions	14
Using ecological momentary assessment to quantify Δ‐9‐tetrahydrocannabinol and cannabidiol use across different forms of cannabis: Feasibility in a sample of Canadian young adults reporting frequent c	14
Association between change in alcohol use reported during routine healthcare screening and change in subsequent hospitalization: A retrospective cohort study	14
Addiction Lives: Viv Evans	14
	13
On the duration of cannabis effects and the presence of THC in the body	13
Evaluation of the effectiveness of cytisine for the treatment of smoking cessation: A systematic review and meta‐analysis	13
The impacts of COVID‐19 measures on drug markets and drug use among a cohort of people who use methamphetamine in Victoria, Australia	13
Mortality in the SuperMIX cohort of people who inject drugs in Melbourne, Australia: a prospective observational study	13
Effect of perioperative high‐dose transdermal nicotine patch on pain sensitivity among male abstinent tobacco smokers undergoing abdominal surgery: A randomized controlled pilot study	13
Drunken snakes and sober owls: ancient authors on the relationship between animals and wine	13
Quantification of racial and ethnic disparities in alcohol‐related problems in light of different methodological approaches	13
Effect of 3 months and 12 months of financial incentives on 12‐month postpartum smoking cessation maintenance: A randomized controlled trial	13
Within‐week associations between alcohol and other substance use and interaction with naltrexone among sexual and gender minority men in San Francisco, California, USA	13
Within‐person associations of escalated electronic nicotine delivery systems use with cigarette, alcohol, marijuana and drug use behaviors among US young adults	13
Changes to our Editorial Team	13
Commentary on Hyland et al.: Digital treatment for alcohol use disorders ‐ challenges and opportunities	13
Amphetamine use and mental health difficulties across adolescence and young adulthood: An integrative data analysis of four Australasian cohort studies	13
Understanding perceived addiction to and addictiveness of electronic cigarettes among electronic cigarette users: a cross‐sectional analysis of the International Tobacco Control Smoking and Vaping (IT	13
Prolonged diacetylmorphine take‐home during the COVID‐19 pandemic—Results of a retrospective cohort study	13
Issue Information	13
Evaluating the effectiveness of e‐cigarettes compared with usual care for smoking cessation when offered to smokers at homeless centres: protocol for a multi‐centre cluster‐randomized controlled trial	12
Commentary on Manthey et al .: No more missed opportunities—We need to address the absence of robust and comprehensive evaluations about the real‐world i	12
Efficacy of cannabidiol alone or in combination with Δ‐9‐tetrahydrocannabinol for the management of substance use disorders: An umbrella review of the evidence	12
Deaths of despair	12
Classifying national drinking patterns in Europe between 2000 and 2019: A clustering approach using comparable exposure data	12
Referees	12
Standardised packs and larger health warnings: visual attention and perceptions among Colombian smokers and non‐smokers	12
Predicting severe alcohol use disorders in primary care using number of heavy drinking days	12
Clinical management of psychostimulant withdrawal: review of the evidence	12
Decentering alcohol: Non‐drug pleasure and reinforcement as an alternative target	12
Comparison of strength and adulteration between illicit drugs obtained from cryptomarkets versus off‐line	12
Population‐level impact of initiating pharmacotherapy and linking to care people with opioid use disorder at inpatient medically managed withdrawal programs: an effectiveness and cost‐effectiveness an	12
Cannabis policy bundles and traffic fatalities in the American States over time	12
A systematic review and meta‐analysis of factors associated with adolescent substance use in Africa, 2000 to 2020	12
Alcohol use disorder criteria exhibit different comorbidity patterns	12
Packaging of disposable vaping products and e‐liquids in England, Canada and the United States: A content analysis	12
Changing trends in drug overdose mortality in Spain, 2001–2022	12
Post‐legalization shifts in cannabis use among young adults in Georgia—A nationally representative study	12
The impact of road safety policies in a deregulated alcohol tax environment in Hong Kong: a 15‐year time series analysis	12
Development and evaluation of a risk algorithm predicting alcohol dependence after early onset of regular alcohol use	12
Evaluation of statewide restrictions on e‐cigarette nicotine strength—United States, 2017–2022	12
Understanding successful policy innovation: The case of Portuguese drug policy	12
Is methamphetamine blood concentration in emergency department patients associated with the clinical picture?	12
How much does the absence of the ‘hidden population’ from United Kingdom household surveys underestimate smoking prevalence?	12
How effective are remote and/or digital interventions as part of alcohol and drug treatment and recovery support? A systematic review and meta‐analysis	12
Socio‐economic inequalities in smoking and drinking in adolescence: Assessment of social network dynamics	11
Commentary on Bade et al.: Threat of nitazenes and other potent synthetic opioids—Is Europe prepared? Time to respond and to learn	11
Nitrous oxide: The label ‘potentially addictive’ may do more harm than good	11
Why it is important to conduct gambling research that is fair and free from conflicts of interest	11
Does a local Alcohol Health Champion programme have a measurable impact on health and crime outcomes? A natural experiment evaluation of Communities in Charge of Alcohol (CICA) based on triangulation	11
E‐cigarette cessation and transitions in combusted tobacco smoking status: longitudinal findings from the US FDA PATH Study	11
Predictors of alcohol and other drug treatment completion among young people accessing residential and community‐based treatment: A retrospective analysis of routinely collected service data	11
GLP‐1R agonist medications for addiction treatment	11
Drug consumption rooms are effective to reduce at‐risk practices associated with HIV/HCV infections among people who inject drugs: Results from the COSINUS cohort study	11
Non‐alcoholic beer labeling in the United States	11
Future Directions for the International Cannabis Toolkit (iCannToolkit)	11
Will Australia's tightened prescription system reduce nicotine vaping among young people?	11
Issue Information	11
Let's talk about pleasure: Bridging the sociology and public health divide	11
Commentary on Dennett et al .: When heat and the opioid epidemic collide ‐ implications for climate‐resilient public health strategies	11
Delta‐8 tetrahydrocannabinol: a scoping review and commentary	11
Cannabis and sport: A World Anti‐Doping perspective	11
Electronic cigarettes and subsequent use of cigarettes in young people: An evidence and gap map	11
Changes to our editorial team	11
The risks of misclassifying addictive food substances as non‐addictive	11
When should we conduct large‐scale evaluations?	11
Co‐action and changes in alcohol use during a smoking cessation attempt	11
The environmental impact of tobacco products: Time to increase awareness and action	11
Affected other interventions: a systematic review and meta‐analysis across addictions	11
Prenatal smoking, alcohol and caffeine exposure and offspring externalizing disorders: a systematic review and meta‐analysis	11
Cannabidiol does not attenuate acute delta‐9‐tetrahydrocannabinol‐induced attentional bias in healthy volunteers: A randomised, double‐blind, cross‐over study	10
Behavioral stability of alcohol consumption and socio‐demographic correlates of change among a nationally representative cohort of US adults	10
Commentary on Weinberger et al.: Tobacco and cannabis policies as drivers of nicotine and cannabis co‐use ‐ research and measurement implications to move the field forward	10